SynergyMed is a medical device company with a proven technology, focused on the treatment of cancer tumors as an alternative to surgical resection for human and veterinary applications. The company is at the pre-clinical stage with a prototype and animal data, and is currently seeking a seed investment to launch its product into the veterinary market. The platform technology is intended for human breast cancer and other superficial cancer tumors.